Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficient evidence-based genome annotation with EviAnn.

Nature methods·2026
Same author

Ambiguity in identifying parameters of an SIR model when fitting epidemic incidence data.

Mathematical biosciences and engineering : MBE·2026
Same author

Efficient evidence-based genome annotation with EviAnn.

bioRxiv : the preprint server for biology·2025
Same author

Laminar chaotic saddle within a turbulent attractor.

Physical review. E·2024
Same author

Finding Hopf bifurcation islands and identifying thresholds for success or failure in oncolytic viral therapy.

Mathematical biosciences·2024
Same author

Robust steady states in ecosystems with symmetries.

Journal of biological dynamics·2023

Related Experiment Video

Updated: Jul 19, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

Reconciling different infectivity estimates for HIV-1.

Brandy L Rapatski1, Frederick Suppe, James A Yorke

  • 1Natural Sciences and Mathematics, NAMS, Richard Stockton College of New Jersey, Pomona, 08240, USA. Brandy.Rapatski@stockton.edu

Journal of Acquired Immune Deficiency Syndromes (1999)
|September 28, 2006
PubMed
Summary

HIV transmission risk is highest during the symptomatic stage, challenging existing research. This finding has critical implications for understanding and controlling the spread of Human Immunodeficiency Virus (HIV).

More Related Videos

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
11:19

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

Published on: May 4, 2015

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Jul 19, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
11:19

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

Published on: May 4, 2015

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Area of Science:

  • Epidemiology
  • Virology
  • Public Health

Background:

  • Current literature suggests early-stage Human Immunodeficiency Virus type 1 (HIV-1) infection poses the highest transmission risk.
  • Previous studies, such as Jacquez et al., identified the primary stage as the most infectious period.
  • The Wawer et al. study indicated peak transmission within the first 5 months post-infection in monogamous heterosexual couples.

Discussion:

  • This article challenges the established understanding by presenting evidence that HIV-1 transmission probability is significantly higher during the third, symptomatic stage of the disease, particularly through casual sexual contact.
  • The findings contrast with prevailing research that emphasizes early-stage infectivity.
  • The authors reconcile their results with the Wawer et al. study, suggesting compatibility between late-stage transmission and early infection dynamics.

Key Insights:

  • Late-stage symptomatic Human Immunodeficiency Virus (HIV) infection presents a substantially elevated risk for sexual transmission compared to earlier stages.
  • This research offers a new perspective on HIV-1 epidemic drivers, shifting focus from early to late-stage disease.
  • The study provides a critical re-evaluation of existing HIV transmission models.

Outlook:

  • Further research is needed to elucidate the virological and immunological factors contributing to increased infectivity in late-stage HIV-1 disease.
  • Public health strategies may require re-evaluation to incorporate the heightened transmission risk associated with symptomatic HIV-1 infection.
  • Understanding transmission dynamics across all disease stages is crucial for effective HIV prevention and control efforts.